New CRM ParadigmPrecision Adherence

Patients don’t take their drugs

32 million Americans use three or more medicines daily.

75% of adults are non-adherent in one or more ways.

The economic impact of non-adherence is estimated to cost $100 billion annually

CRM program

Current State

Expensive marketingbudgets

PII & PHI collection

HIPAA & CANSPAM

Marketing consent

Data protection

Most CRM programsfail

Paradigm shift

Precision Adherence

Patient is subject of record

Data Synchronicity

There is no PII PHI Present. Nothing is ever storedNo visibility to patient

No Residual Records

Databases toDashboards

If “Diabetes” analyze data

Analyze all Diabetes Patients Using Which Drug

Who have Filled What PrescriptionWho Have What Dosing

In What Stage of the ConditionMeasured by What Biometric

etc

Advanced Filtering

With Diabetes

Diabetes + High Blood Pressure

Diabetes + High Blood Pressure + Failed Metformin

Diabetes + High Blood Pressure + Failed Metformin + Prescribed GLP-1

Diabetes + High Blood Pressure + Failed Metformin + Prescribed GLP-1+ With A1C >

11

Diabetes + High Blood Pressure + Failed Metformin + Prescribed GLP-1+ With an

A1C>11 +Missed Last Doctors Appointment

Diabetes + High Blood Pressure + Failed Metformin + Prescribed GLP-1+ With an

A1C>11 +Missed Last Doctors Appointment+ Did not refill last prescription

Not AdherencePersonalized Support

Prescription History

Extended Care Team

Personal HealthProgram

Days on Drug,Switch, & ROI

Patient Relationship Management

Patient Managed Relationship

Patient: Better personal adherence, better health

Payer: Evidence based adherence and better outcomes and lower net costs

Pharma: Precision behavior modification mechanism that reduces

risk and increases revenue

Benefits

Q&A